Skip to main content
Premium Trial:

Request an Annual Quote

Dan Calvo, George Dunbar

Premium
Accuri Cytometers this week announced the appointment of Dan Calvo and George Dunbar to newly created positions on its board of directors.
 
Dunbar is currently president, CEO, and a director of Aastrom Biosciences, a company specializing in autologous stem cell products for use in regenerative medicine.
 
Prior to Aastrom,  Dunbar served as CEO of several life science companies including Quantum Dot Corporation, Targesome, Epic Therapeutics, Cytotherapeutics, Stem Cells, and Metra Biosystems. Earlier in his career, Dunbar held management positions with the Ares-Serono Group and Amersham International.
 

Calvo is currently president and CEO of Assay Designs, which provides research assays and reagents to biomedical, pharmaceutical, and translational research companies. Prior to Assay Designs, Calvo was CEO of Cellomics. Previously, Calvo held positions with PerkinElmer Life and Analytical Sciences, NEN Life Sciences, and DuPont.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.